In-hospital mortality | |||||
RRUY | |||||
RRAU | 0.5 | 0.6 | 0.7 | 0.8 | 0.9 |
0.5 | (,) | 11.42 (2.82 to 20.01) | −1.41 (−7.00 to 4.17) | −5.69 (−10.38 to −1.00) | −7.83 (−12.1 to −3.55) |
0.6 | 11.42 (2.82 to 20.01) | −0.9 (−6.60 to 4.8) | −5.01 (−9.83 to −0.18) | −7.06 (−11.48 to −2.64) | −8.29 (−12.48 to −4.1) |
0.7 | −1.41 (−7.00 to 4.17) | −5.01 (−9.83 to −0.18) | −6.8 (−11.27 to −2.33) | −7.88 (−12.15 to −3.61) | −8.6 (−12.73 to −4.46) |
0.8 | −5.69 (−10.38 to −1.00) | −7.06 (−11.48 to −2.64) | −7.88 (−12.15 to −3.61) | −8.43 (−12.59 to −4.26) | −8.82 (−12.92 to −4.72) |
0.9 | −7.83 (−12.10 to −3.55) | −8.29 (−12.48 to −4.10) | −8.6 (−12.73 to −4.46) | −8.82 (−12.92 to −4.72) | −8.98 (−13.05 to −4.91) |
Major complications | |||||
RRUY | |||||
RRAU | 0.5 | 0.6 | 0.7 | 0.8 | 0.9 |
0.5 | (,) | 8.57 (5.31 to 11.83) | 1.98 (−1.68 to 5.64) | −2.96 (−7.01 to 1.10) | −6.8 (−11.2 to −2.40) |
0.6 | 8.57 (5.31 to 11.83) | 2.42 (−1.21 to 6.05) | −1.97 (−5.94 to 2.00) | −5.26 (−9.52 to −1.00) | −7.82 (−12.32 to −3.32) |
0.7 | 1.98 (−1.68 to 5.64) | −1.97 (−5.94 to 2.00) | −4.79 (−9.01 to −0.57) | −6.91 (−11.32 to −2.5) | −8.55 (−13.12 to −3.99) |
0.8 | −2.96 (−7.01 to 1.10) | −5.26 (−9.52 to −1.00) | −6.91 (−11.32 to −2.5) | −8.14 (−12.67 to −3.61) | −9.1 (−13.72 to −4.48) |
0.9 | −6.8 (−11.2 to −2.4) | −7.82 (−12.32 to −3.32) | −8.55 (−13.12 to −3.99) | −9.1 (−13.72 to −4.48) | −9.53 (−14.19 to −4.87) |
The change in levels corresponds to the accreditation average marginal effect of all the postperiod.
* If following accreditation, there is a 40% increase in reports of comorbidities only due to changes in coding practices, then RRAU=0.7 (1/1.4); and if patients who were more susceptible to having their comorbidities under-reported in the preaccreditation area (mostly older patients) are 25% more likely to die than other patients, then RRUY=0.8 (1/1.25). Therefore, the corrected reduction in in-hospital mortality following accreditation is −7.88 percentage points (95% CI −12.15 to −3.61).